Dostarlimab + Chemo Beneficial for Advanced, Recurrent Endometrial Cancer

MONDAY, June 9, 2025 (HealthDay News) -- For patients with advanced or recurrent endometrial cancer, dostarlimab plus carboplatin-paclitaxel treatment is associ